Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2 for:    WVE-210201
Previous Study | Return to List | Next Study

Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy (DYSTANCE 51)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03907072
Recruitment Status : Terminated (Lack of efficacy)
First Posted : April 8, 2019
Last Update Posted : January 18, 2020
Sponsor:
Information provided by (Responsible Party):
Wave Life Sciences Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 16, 2019
Actual Study Completion Date : January 9, 2020